QuidelOrtho Corp
QDEL
View Detailed Chart
29.820USD
+0.870+3.01%
Market hours （ET）Quotes delayed by 15 min
2.02BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.01%
5 Days
+3.54%
1 Month
+22.46%
6 Months
+6.39%
Year to Date
-33.06%
1 Year
-33.50%
View Detailed Chart
TradingKey Stock Score of QuidelOrtho Corp
Currency: USD Updated: 2025-12-19Key Insights
QuidelOrtho Corp's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 61/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 36.86.In the medium term, the stock price is expected to remain stable.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
QuidelOrtho Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Hold
Current Rating
36.857
Target Price
+35.70%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
QuidelOrtho Corp Highlights
StrengthsRisks
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Fairly Valued
The company’s latest PE is -1.66, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 79.44M shares, decreasing 22.58% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 245.91K shares of this stock.
QuidelOrtho Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
QuidelOrtho Corp Info
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Ticker SymbolQDEL
CompanyQuidelOrtho Corp
CEOBlaser (Brian J)
Websitehttps://www.quidelortho.com/
FAQs
What is the current price of QuidelOrtho Corp (QDEL)?
The current price of QuidelOrtho Corp (QDEL) is 29.820.
What is the symbol of QuidelOrtho Corp?
The ticker symbol of QuidelOrtho Corp is QDEL.
What is the 52-week high of QuidelOrtho Corp?
The 52-week high of QuidelOrtho Corp is 49.450.
What is the 52-week low of QuidelOrtho Corp?
The 52-week low of QuidelOrtho Corp is 19.500.
What is the market capitalization of QuidelOrtho Corp?
The market capitalization of QuidelOrtho Corp is 2.02B.
What is the net income of QuidelOrtho Corp?
The net income of QuidelOrtho Corp is -2.05B.
Is QuidelOrtho Corp (QDEL) currently rated as Buy, Hold, or Sell?
According to analysts, QuidelOrtho Corp (QDEL) has an overall rating of Hold, with a price target of 36.857.
What is the Earnings Per Share (EPS TTM) of QuidelOrtho Corp (QDEL)?
The Earnings Per Share (EPS TTM) of QuidelOrtho Corp (QDEL) is -17.401.
Related Instruments
-0.72%
-0.24%
+1.13%
+1.35%
+1.36%
+0.77%
+0.29%
-0.95%
-0.32%
+0.89%
+1.05%
+1.21%
-0.42%
+0.54%
+0.09%
+0.96%
+0.69%
+0.81%
+1.22%
+0.59%
